Daily Market Movers 04-01-10

FEATURED COMPANY

MUSCLE FLEX INCORPORATED (OTC: MFLI)

Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php

Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm

Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast.

MFLI News:

April 1 - BRAVADA / Muscle Flex Launches its New Muscle Flex VATA Brasil Ecommerce Website Heading into its April 8, 2010 Official Launch Party with Kim Kardashian

BRAVADA / Muscle Flex Inc. (OTC: MFLI) announced that it has launched its new Muscle Flex VATA Ecommerce website for its Muscle Flex VATA Brasil Sports and Active Wear Collection at www.MuscleFlexVATA.net ahead of its April 8 BRAVADA International official launch party with Kim Kardashian. The new Muscle Flex VATA website, which will be www.MuscleFlexVATA.com shortly, features over 1500 product images and utilizes the most advanced development source code and technology from search engine optimization, fast and efficient page downloads as well as a next generation shopping cart and order processing system.

BRAVADA / Muscle Flex recently announced its red carpet BRAVADA Couture / Muscle Flex VATA Brasil National Launch Party with Kim Kardashian to be held at The Whisper Lounge located inside The Grove in Los Angeles, California on Thursday April 8, 2010. Kim Kardashian aligned with BRAVADA™ / Muscle Flex® to represent and promote the sassy and sexy Brasilian inspired sports and active wear collection. This gala Hollywood launch party will showcase BRAVADA / Muscle Flex VATA to a cavalcade of national media attendees with a number of additional A-list celebrities expecting to attend. Additional announcements are expected next week.

With the Launch of BRAVADA’s next generation Muscle Flex VATA website, BRAVADA will begin an aggressive and focused online marketing initiative that will begin April 8 with its official launch party. BRAVADA / Muscle Flex will also soon be releasing a companion website, BravadaBrasil.com. MuscleFlexVATA.com will sell the Muscle Flex VATA Brasil Sports and Active Wear Collection exclusively while BravadaBrasil.com shall sell the same Muscle Flex VATA Brasil line with additional Brasilian inspired pieces and accessories. The web strategy associated with its 3 website approach (BravadaCouture.com, Muscle FlexVATA.com and BravadaBrasil.com) is a highly effective next generation method of providing an incredible degree of search engine optimization on a level that is far superior as compared to marketing a single online site. Search engine optimization is the #1 focus of BRAVADA / Muscle Flex’s online ecommerce strategy. This method of multiple online website marketing for search engine optimization is one that involves a process that is considered a next generation approach of optimizing internet presence.

FEATURED COMPANY

PRECIOUS METALS EXCHANGE CORPORATION (OTC: PRMX)

Detailed Quote: http://www.otcpicks.com/quotes/PRMX.php

Company Profile: http://www.otcpicks.com/precious-metals-exchange.htm

Precious Metal Exchange Corp. is a publicly traded company that has a novel approach to gold and silver trading that offers the added convenience and safety of "high tech" bearer certificates. The company has smelting, minting, and plating facilities as well as high tech assay capabilities. Precious Metals Exchange Corp. is in the precious metals refining and recycling sector of the precious metals industry. The Company will provide a convenient, secure and efficient method for customers to sell items containing precious metals. Targeted direct marketing is used to identify potential customers, and a highly automated fulfillment process to ensure their satisfaction through high payouts and quick service. The Company will recycle customers' broken or unwanted jewelry and other items for gold, platinum and silver content, avoiding the risks and environmental costs of mining.

PRMX News:

March 30 - Precious Metals Exchange Corp. Names Head of Business Development Department

Precious Metals Exchange Corp. (OTC: PRMX) announced the hiring of Jason Ford to head the business development department for PRMX. His duties will involve the coordinating of the move to the new Precious Metals Exchange location and completing the first phase of the Company's unique business plan.

Ford attended Northwood University in Dallas, Texas and graduated Magna Cum Laude with a BBA in Business Administration. While attending Northwood on a baseball scholarship, he earned Division I Baseball All American honors and still holds numerous league and school records including the Division I Triple Crown with a single season record batting average of .456. He was also elected to the All Conference Team each season of his playing career and was chosen Most Valuable Player for each season he participated while maintaining a perfect 4.0 GPA. Ford is listed in Who's Who in America.

Ken Dougherty, Chairman and President of Precious Metals, said, "We look forward to Jason coming on board. Jason's past working experience will be an asset to the company's Business Development Department."

Ford has been involved with Caritas Ranch BBQ since 1994 working in all phases of the Boerne, Texas meat packing plant. His business career also includes Territory Manager for Martin Fletcher & Associates in Dallas, as well as the Salad Bowl franchise operation headquartered in Dallas, TX. He is a Licensed Insurance Agent representing Benefit Architects and is in the process of obtaining his Broker-Dealer Certification.

Ford stated, "People need an option for asset protection and PRMX offers the only game in town. The response to PRMX's business plan has been overwhelming and I look forward to perfecting a product that is truly a capital preservation company with the least risk in the market place. PRMX is able to offer services previously unavailable to the consumer. People who are looking for the ultimate protection in these troubled times will find that PRMX has the products that they are looking for and every American needs."

FEATURED COMPANY

OROFINO GOLD CORPORATION (OTC: ORFG)

Detailed Quote: http://www.otcpicks.com/quotes/ORFG.php

Company Profile: http://www.otcpicks.com/orofino-gold/orofino-gold.htm

Orofino Gold is a precious metals acquisition, exploration, and development company. The Company acquires and explores strategically-located precious metals properties in the historically rich gold bearing jurisdictions of Colombia and Mexico. To this end OROFINO has signed an option agreement to acquire several properties in Colombia. The Company is listed on the Pink Sheets under the symbol ORFG.

ORFG News:

March 30 - Orofino Gold Corp. Announces Exceptional Results Validation due April 8th

Orofino Gold Corp. (OTC: ORFG) ("Orofino Gold" or the "Company") announces that the initial results from mineralized and un-mineralized material samples, as well as selected representative samples collected from its Colombian projects that ran higher than expected in gold, silver and copper will be re-assayed, these results will be available on or before April 8th, 2010. These results will form part of a future NI 43-101 compliant review of previous exploration and field data as well as recommendations and budgets.

FEATURED COMPANY

YESDTC HOLDINGS INCORPORATED (OTCBB: YESD)

Detailed Quote: www.otcpicks.com/quotes/YESD.php

Company Profile: http://www.otcpicks.com/yesdtc-holdings/yesdtc-holdings.htm

YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), Internet and retail marketing programs. The Company brings a unique set of skills to this marketplace. YesDTC combines both creative talents and financial acumen to create a total package for direct-to-consumer marketing programs. We have formed a strategic partnership with Schulberg Media Works (SMW), one of the pioneering firms in the direct-to-consumer space. SMW's track record is impressive with nearly $1 billion in revenues and a strong track record of industry awards. SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins, PureSleep, among many others.

YESD News:

March 24 - YesDTC Announces the Appointment of William ("Bill") Bush as Chief Financial Officer

YesDTC Holdings, Inc. (OTCBB: YESD), a direct-to-consumer global distributor and marketer of consumer goods and products, today announced the appointment of William ("Bill") Bush as the Company's Chief Financial Officer. Mr. Bush has over 20 years of experience in accounting, financial support and business development, including his most recent success serving as CFO of the leading manufacturer of solar panels in India, helping the company to reach $100 million in sales in its first 15 months of operation.

Additionally, prior to joining YesDTC, Mr. Bush accumulated significant experience in the role of chief financial officer for several high growth software and online media companies with responsibilities for establishing business processes, capital raising, business development and investor relations. Throughout his career, he has also served in the roles of business development and corporate controller and spent seven years in public accounting with Ernst & Young and Price Waterhouse.

Bill holds a B.S. in Business Administration from U.C. Berkeley and is a Certified Public Accountant. He currently serves on the Board of Towerstream, a leading supplier of WiMax services; FindEx.com, a Bible study software provider; and ThinIdentity, a private developer and distributor of virtualization solutions for the medical industry.

STOCKS TO WATCH

ELECTRIC CAR COMPANY INCORPORATED (OTCBB: ELCR)
"Up 94.59% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ELCR.php

Electric Car Company, Inc. is a vehicle conversion company that specializes in electric conversion and manufacturing for the livery and fleet markets including corporate VIP, Party Buses, Municipal Buses and Delivery Vehicles. The company brings together businesses specializing in customizing vehicles and powertrains. This proven business strategy is building a dominating presence in the aftermarket automotive up-fitter segment, including, but not limited to "Pure Electric" cars, liquid propane conversions, limousines & other livery vehicles, specialty fleet vehicles, classic automobiles and custom restorations. The Company fully expects to have the first zero emissions, "Pure Electric" livery vehicle ready to unveil by second quarter of 2010. The long-term strategy is to offer and expand the company's line of products that will revolutionize the specialty automotive vehicle market. Electric Car Company's wholly owned subsidiary, Imperial Coach Works, Inc. and its custom manufacturing division, Imperial Coach Builders, Inc., is a limousine and specialty vehicle manufacturing entity that operates out of a 60,000-square foot facility in Springfield, MO.

ELCR News:

March 31 - Electric Car Company, Inc. Utilizes Grant From the State of Missouri to Increase Efficiency and Lower Overhead Costs

Lean Manufacturing Process Gives Company Competitive Advantage

Electric Car Company, Inc. (OTCBB: ELCR), a vehicle conversion company that specializes in electric conversions and manufacturing for the Livery and Fleet Markets, announces that the Company has utilized a training Grant from the State of Missouri to increase efficiency and lower overhead costs. Implementing "Lean Manufacturing" processes and lowering overall manufacturing costs gives the Company a competitive advantage in the market.

By utilizing the Training Grant awarded to the Company, an independent team of efficiency experts was hired to help overhaul its production process at no cost to The Electric Car Company. The goal is to drastically reduce lead-time and mistakes while improving staffing for the job by reconfiguring traditional assembly lines into productive cells based on one-piece flow.

As a result several steps were taken. The Company has been able to reduce its full time assembly force from 30 down to 19. Any additional labor will be brought in on a job-by-job basis, which also saves on excessive overtime costs. Other areas have been streamlined such as the accounting, marketing and administrative staff that have been reduced by 50%.

The Company has also taken steps to ramp up sales by reducing the salary expense of its sales personnel while increasing the commission structure. This has proven to be very effective with the evidence of the increased sales and contract work brought into the Company in the first quarter of this year.

Mr. Gary Spaniak, CEO of Electric Car Company, Inc. stated, "By utilizing the programs offered by the state, we've been able to continue training at a minimal cost to the company." Mr. Spaniak continued by stating, "The staff is on board with it all. It's not only made us leaner, but it has made us stronger, as well."

DENARII RESOURCES INCORPORATED (OTCBB: DNRR)
"Up 15.62% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/DNRR.php

Denarii Resources Inc. is in the mineral resource exploration and development business and currently owns a 100% interest in the McNab Molybdenum property located in South-West, British Columbia, Canada. Denarii has also entered into an agreement to acquire two coal concessions in Chile, South America. Denarii is continually moving forward with researching and acquiring multiple assets that it hopes will generate positive cash flow for Denarii. Denarii is presently reviewing a number of precious metal properties. These properties are near or in production Gold and Silver properties located in North, South and Latin America. Specifically included in the companies due diligence is a Gold property in South-East California and a Gold, Silver and Copper property in South America, as previously announced in other corporate news releases. Denarii was founded in 2006 and is based in Carson City, Nevada.

DNRR News:

March 23 - Denarii Resources Announces New Appointment to Board of Directors

Denarii Resources Inc. (OTCBB: DNRR) (Berlin & Frankfurt: 8D3) announced that Dennis Lorrig has, effective immediately, consented to act as an officer and director of the company and will serve as the new corporate President. Mr. Lorrig is a resident of San Diego, California and has a Bachelor of Science Degree, majoring in Math and Economics, and a minor in Applied Engineering at the University of Wisconsin-La Crosse and attended Business Grad School at UW-Green Bay. He previously worked at the Green Bay Engineering Corps at Proctor and Gamble and also has worked for a number of major corporations in developing strategic product growth. He has also assisted in many charitable fund raising events. The company feels very confident that his engineering background coupled with his ability to raise capital will be very beneficial for the next stage of development for the corporation.

Denarii Resources Inc. has accepted the resignation of Mr. Stuart Carnie and would like to thank Stuart Carnie for his past service to the company and extends its best wishes for his future endeavors.

EVOLUTION FUELS INCORPORATED (OTC: EVFN)
"Up 83.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/EVFN.php

Evolution Fuels, Inc. endeavors to market renewable transportation fuels at retail fuel stations that will provide blends of ethanol from 10% to 85% (E10 to E85), and biodiesel blends from 5% to 20% (B5 to B20). The Company’s plan calls for the development of a chain of renewable fuel stations that extend from Texas to Mississippi that will be a combination of “Evolution Fuels”-branded fuel stations/convenience stores and western-motif truck stops modeled after the Willie’s Place Truck Stop in Carl’s Corner, TX.

EVFN News:

April 1 - Evolution Fuels Considers Compressed Natural Gas as Additional Product Offering

Evolution Fuels, Inc. (OTC: EVFN) (the "Company") announced that it is currently evaluating opportunities for the inclusion of the sale of compressed natural gas (CNG) at the Company's fuel station in Dallas, TX, which is currently in the design phase. The Company envisions the sale of CNG from dispensers co-located with its ethanol blending dispensers.

Evolution Fuels CEO, Dennis McLaughlin, said, "We are seeing local increased activity related to the use of CNG as a transportation fuel from various sectors. The City of Dallas utilizes numerous fleet vehicles already using CNG, local automobile conversion facilities are converting more and more private fleet vehicles over to CNG, and there are new and existing local, state, and federal incentive programs in place for the implementation of CNG. We have even been in touch with a large independent natural gas production company to discuss implementing CNG dispensers at future fueling stations in this region of the United States. I believe it is safe to say that the Dallas-Fort Worth metroplex market for publicly-available CNG is currently underserved."

Company management stated that it has obtained quotes for the implementation of the CNG dispensers and necessary equipment and is currently evaluating the economics for the project.

GENTIUM S.P.A. (NASDAQ: GENT)
"Up 87.77% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GENT.php

Gentium S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the development and manufacture of drugs to treat and prevent a variety of diseases and conditions, including vascular diseases related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan Drug status by the U.S. FDA and Orphan Medicinal Product Designation by the European Commission both to treat and to prevent VOD and Fast Track Designation by the U.S. FDA to treat VOD.

GENT News:

March 31 - Gentium Announces Fourth Quarter and Year End 2009 Results

- Revenues increase by 78% compared with 2008
- 60% decrease in cash burn for operating activities
- Cash flow positive in Q4/2009 and expects to remain positive for 2010
- Expected revenue in 2010 to be in the range of $20 - $25 million

Gentium S.p.A. (Nasdaq: GENT) reported financial results for the quarter and year ended December 31, 2009. The Company reports its financial condition and operating results using U.S. Generally Accepted Accounting Principles (GAAP). The Company's financial statements are prepared using the Euro as its functional currency. On December 31, 2009, EUR 1.00 = $1.4332.

"Total product sales rose 78 percent in 2009 resulting from the successful implementation of the named-patient program in Europe and cost recovery program in the U.S.," stated Gary Gemignani, Executive Vice President and Chief Financial Officer of Gentium S.p.A. "For the fourth quarter 2009, we reported positive operating cash flow. We expect revenues in 2010 to be in the range of $20 - $25 million and cash flow to be positive in 2010."

"We are pleased that Defibrotide was selected as one of the highlights at the American Society of Hematology (ASH) conference and more recently at European Bone Marrow Transplant (EBMT) conference," stated Dr. Khalid Islam, Chief Executive Officer of Gentium S.p.A. "We are currently completing certain preclinical and clinical studies requested by regulatory authorities and we anticipate filing for regulatory approval in the U.S. and Europe by the end of second quarter 2011. With the $7 million upfront payment in connection with our recent expansion of the license and cost sharing agreements with Sigma-Tau and substantial revenues being generated by the named-patient program, we have significantly strengthened our balance sheet."

Financial Highlights

For the fourth quarter ended December 31, 2009 compared to the prior year's fourth quarter:

* Total revenues were EUR 4.05 million, compared with EUR 1.04 million
* Operating costs and expenses were EUR 4.08 million, compared with EUR 4.88 million
* Research and development expenses, which are included in operating costs and expenses, were EUR 0.86 million, compared with EUR 1.70 million
* Operating loss was EUR 0.04 million, compared with EUR 3.84 million
* Interest income/(expense), net, was EUR (0.01) million, compared with EUR 0.08 million.
* Pre-tax loss was EUR 0.05 million, compared with EUR 3.45 million
* Net loss was EUR 0.05 million, compared with EUR 3.45 million
* Basic and diluted net loss per share was EUR 0.003, compared with EUR 0.23 per share

For the year ended December 31, 2009 compared with the prior year:

* Total revenues were EUR 10.17 million, compared with EUR 7.44 million
* Operating costs and expenses were EUR 14.75 million, compared with EUR 27.77 million, which included a write-down of assets of EUR 3.40 million
* Research and development expenses, which are included in operating costs and expenses, were EUR 3.51 million, compared with EUR 9.57 million
* Operating loss was EUR 4.58 million, compared with EUR 20.33 million, which included a write-down of EUR 3.4 million in assets
* Interest income/(expense), net, was EUR (0.11) million, compared with EUR 0.25 million
* Net loss was EUR 4.53 million, compared with EUR 19.90 million, which included a write-down of EUR 3.4 million in assets
* Basic and diluted net loss per share was EUR 0.30 compared with EUR 1.33 per share
* Cash used in operating activities was EUR 5.16 million, compared with EUR 12.78 million
* Cash and cash equivalents amounted to EUR 1.39 million as of December 31, 2009

Recent Company Highlights

Gentium announced that it amended its existing License and Supply and Cost Sharing Agreements with Sigma-Tau Pharmaceuticals, Inc., to include a license for the prevention indication of Defibrotide in the Americas. Gentium will continue to own exclusive rights to Defibrotide in Europe and the rest of the world.

In March 2010, Gentium announced management and corporate restructuring changes resulting from a strategic decision to consolidate the Company's resources and operations within Italy. Mr. Gary Gemignani, Executive Vice-President and Chief Financial Officer is leaving the Company, effective today, but will provide transitional services through a consulting agreement.

The Company presented an abstract containing the final results for the Phase II/III pediatric prevention trial of Defibrotide for the prevention of VOD at the annual meetings of ASH and EBMT. In the intent to treat analysis Defibrotide demonstrated a 40% reduction in the incidence of VOD within 30 days after SCT, the primary endpoint of the study. In addition, a pre-specified analysis showed that the incidence and severity of acute graft versus host disease by day 100 in allogeneic SCT recipients was significantly reduced from 63% for the control arm to 45% for the prophylaxis arm.

Operating Results

Product sales were EUR 9.70 million for 2009 compared to EUR 5.44 million for 2008, an increase of EUR 4.26 million or 78%. The increase was primarily due to the launch in April 2009 of the named-patient program and the launch in September 2009 of the cost recovery program in the U.S. Named-patient program and cost recovery program sales, net, for the year ended December 31, 2009 amounted to EUR 4.90 million, which are net of EUR 0.79 million of service fees.

The active pharmaceutical ingredient, or API, revenues slightly decreased from EUR 4.79 million in 2008 to EUR 4.6 million, reflecting the decrease in volume of suglicotide offset by a price increase and higher sales volume of urokinase.

Sales to a related party, Sirton, for the year ended December 31, 2009 and 2008 represented 2% and 12% of the total product sales, respectively. The decrease in sales to a related party was primarily due to the fact that in the second quarter of 2009 the Company terminated the supply agreement with Sirton and entered into direct sales agreements with Sirton's customers in order to mitigate the risk associated with Sirton's poor financial condition and terminated the supply agreement with Sirton.

Other revenues were EUR 0.47 million for 2009 compared to EUR 1.99 million for 2008. The decrease versus the prior year is primarily attributable to a decrease in activities that were reimbursed from Sigma Tau under our cost sharing agreement, offset by a milestone payment from Sigma-Tau of $0.35 million for completion of the phase III clinical trial.

Cost of goods sold was EUR 4.0 million for 2009 compared to EUR 5.60 million in 2008. Cost of goods sold as a percentage of product sales, net, was 41% in 2009 compared to 103% in 2008. The percentage decrease is primarily due to higher margins on Defibrotide sold through the named-patient program and price increases in the API business. The Company fully expensed the cost of inventory in the prior year. Additionally, the higher percentage of cost of goods sold in 2008 was primarily due to the fact that product sales to a related party, Sirton, were not recognized in the amount of EUR 1.08 million due to Sirton's poor financial condition and concerns over the ability to collect such receivables.

The Company incurred research and development expenses of EUR 3.51 million in 2009 compared to EUR 9.57 million for 2008. Research and development expenses in 2009 and 2008 are net of EUR 0.85 and EUR 0.79 million, respectively, of government grants in the form of a tax credit. The decrease from the prior year is mainly due to completion of clinical trials.

General and administrative expenses were EUR 6.04 million in 2009 compared to EUR 7.67 million in 2008. In 2008, we established a reserve for doubtful in accounts in the amount of EUR 1.78 million, of which EUR 0.68 was released in 2009. Additionally, the Company had lower payroll costs due to the temporary layoffs under a special public fund used in Italy under the "Cassa Integrazione Guadagni" program and decrease in stock based compensation expenses.

In 2008, the Company recorded an impairment of EUR 3.40 million. Write-down of assets include the write-down of acquired trademarks, marketing authorizations, inventory, and the Company's patents. The trademarks and marketing authorizations have been written-down due to the expiration and non-renewal by the Company of the distribution agreement with Crinos S.p.A., which raised concern about the ability to recover the cost of these assets.

Interest income/(expense), net amounted to EUR (0.11) million and EUR 0.26 million in 2009 and 2008, respectively. The decrease in interest income/(expense), net is a result of a lower amounts of invested funds in 2009 compared to the prior period as well as a decrease in interest rates.

Net loss was EUR 4.53 million in 2009 compared to EUR 19.90 million in 2008. The difference was primarily due to increased net sales and higher margins associated with the named-patient and cost recovery programs and a decrease in development activities related to the treatment and prevention studies.

The Company ended the fourth quarter of 2009 with EUR 1.39 million in cash and cash equivalents, compared with cash and cash equivalents of EUR 11.49 million as of December 31, 2008. Absent the need to fund any additional clinical trials, management believes that the Company's cash and cash equivalents, including the upfront payment received from Sigma-Tau Pharmaceuticals, Inc. in connection with the expansion of the license agreement for Defibrotide in the Americas, together with revenues generated from its named-patient and cost recovery programs, will be sufficient to meet the Company's obligations for at least the next twelve months.

ABOUT VOD

Veno-occlusive disease is a potentially life-threatening condition, which typically occurs as an important complication of stem cell transplantation. Certain high-dose conditioning regimens used as part of SCT can damage the lining cells of hepatic blood vessels and so result in VOD, a blockage of the small veins of the liver that leads to liver failure and can result in significant dysfunction in other organs such as the kidneys and lungs (so-called severe VOD). SCT is a frequently used treatment modality following high-dose chemotherapy and radiation therapy for hematologic cancers and other conditions in both adults and children. There is currently no approved agent for the treatment or prevention of VOD in the US or the EU.

OPTIONS MEDIA GROUP HOLDINGS INCORPORATED (OTCBB: OPMG)
"Up 16.05% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/OPMG.php

Company Profile: http://www.otcpicks.com/options-media-group/options-media-group.htm

Options Media Group Holdings, Inc. is an email services provider for on-demand email marketing to create, send, and track professional and permission-based email marketing campaigns. Additionally, Options Media provides precision direct marketing solutions including email marketing, SMS/mobile marketing, SMS/keyword marketing, custom lead generation and creative services. Options Media provides clients with access to software, hardware, bandwidth, and exclusive domains and IP addresses, as well as the ability to upload and manage subscribers, and review and upload campaigns and track results for a 360-degree full-service customer marketing solution.

OPMG News:

April 1 - Options Media Group States Intent to Enter the Mobile and Smart Phone Anti-Virus Market

Company Signs Letter of Intent to Acquire U.S./Canadian SUB License for NetQin Mobile Anti-Virus, Anti-Harassment Software; Also Agrees to Acquire NetQin Sublicense to Software Solution to Stop Texting While Driving

Options Media Group Holdings, Inc. (OTCBB: OPMG), a growing force in mobile marketing and mobile social media, announced the signing of a letter of intent with PhoneGuard to facilitate its entrance into the lucrative anti-virus, anti-texting while driving, and anti-harassment software market for cell phones and smart phones.

The letter of intent outlines Options Media's acquisition of the North American sublicense from NetQin Tech Co., the incontestable industry leader in mobile security and provider of services (including mobile anti-virus, anti-harassment, and privacy protection) to more than 38 million subscribers in more than 200 countries and regions. Under the terms of the agreement, Options Media will become the exclusive marketer within the United States and Canada of the world-wide number one market share ranking PhoneGuard software suite designed to safeguard cellular phones, PDAs and smartphones from attacks by hackers and cyber criminals.

While most personal computer users have already protected their systems from viruses, spyware and other attacks, most cell and smartphone users, on the other hand, are relatively unaware of the risks presented by a new breed of cyber criminals. Installation of PhoneGuard prevents not only the potential loss of data, but also virtually eliminates the ability for hackers to listen in on phone conversations, pinpoint the user's GPS coordinates, steal information and/or browse personal emails and text information.

"Our mobile devices, especially our smartphones, have moved well beyond providing simple communication and are now highly integrated into our lives. Protection of the valuable data stored on these devices is becoming increasingly important and we believe use of the PhoneGuard product, provided by NetQin, is the best way to protect this important asset," commented Scott Frohman, CEO of Options Media Group. "While North American mobile phone users are just now beginning to realize these risks, users in Asia and Europe have actually already installed millions of copies of this anti-virus software. The North American market is expected by most industry watchers to soon experience the same explosive market growth."

Mr. Frohman continued, "We believe this represents a significant revenue generation opportunity for Options Media Group and we plan to aggressively pursue the closing of this transaction and this market opportunity. We believe our vast experience in the Internet market will allow us to drive awareness and sign-ups for this important service offering, leading to a strong and growing high margin revenue stream for our Company. This leading NetQin software is already in use by tens of millions of mobile phone users in many other countries, with approximately 65% of the large and growing Chinese market utilizing its advanced capabilities at present. We believe the U.S. and Canadian markets represent a similar growth opportunity, especially considering the very low current market penetration rate and the growth threat as cyber criminals become ever more sophisticated."

"This marks the turning point in the quantity, complexity and level of threat mobile viruses and malware present," says Anthony Sasso, founder of PhoneGuard. "Our mobile phones have become an integral part of our day-to-day lives and smartphones are becoming more and more like computers. We are now using these multifunction devices for business communications, email, web surfing, online banking, and so much more. These devices harbor some of our most personal and important information -- and PhoneGuard is here to protect it. With the combined force of Options Media's marketing ability and proven track record of sustaining a strong marketing business combined with the power of NetQin's state of the art industry leading mobile software products topped off with my strong grasp of the mobile sector it presents itself to be a very promising situation for all. The point has come and we are entering the age of the 'Mobile Internet' and the possibilities are endless. I can hardly explain the excitement I feel entering into this venture with the team at Options Media. They have the mental capacity and sheer marketing abilities to help me take this over the top."

A recent report by Gartner declares that smart-phone volumes represented approximately 14 percent of total mobile device sales in 2009, an increase of 23.6 percent over 2008, with a predicted level of 38 percent additional growth by 2013, with over 1.5 billion new smart-phone users worldwide added from 2008 to 2013. Frost & Sullivan forecast sales of mobile anti-malware products to grow to over $1.1 billion by 2011.

ABOUT NETQIN

Established in 2005, NetQin has provided services (including mobile anti-virus, anti-harassment, privacy protection) to more than 30 million subscribers in more than 200 countries and regions. NetQin already has a strong foothold in China, the Middle East, Southeast Asia and Europe. With more than 65% of the mobile security market in China, NetQin is the incontestable industry leader.

Heavily invested in R&D, NetQin owns a broad product line covering the majority of smart phones globally. Their R&D team is composed of more than a 100 person staff, 80% of whom hold a master or doctoral degree. The entire R&D team is highly skilled and experienced in the field of mobile security. With its own intellectual property, NetQin holds over 10 new and unique breakthrough innovations in the field of mobile security. NetQin extensively partners and cooperates with many internationally recognized mobile phone brands and carriers. With NetQin's continued growth, it certainly makes it a worthy recipient of the 2009 China Frost & Sullivan Award for Mobile Security Market Leadership.

ABOUT PHONEGUARD

PhoneGuard is a new software suite specifically designed to safeguard cellular phones/PDAs or smart phones from the ever increasing risk of data theft by hackers and cyber criminals. In conjunction with Cellular Spyware Inc., and powered by NetQin, PhoneGuard is the new wave of protection technology in North America designed to guard users' personal information. PhoneGuard is headquartered at 6400 North Andrews Avenue, Suite 340 in Coconut Creek, Florida.

VIPR INDUSTRIES INCORPORATED (OTC: VIPR)
"Up 21.43% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VIPR.php

VIPR Industries, Inc. offers construction and mining services. It owns and operates gold and uranium mines in Tanzania and Democratic Republic of the Congo. The company, formerly known as Synergy Media, Inc. is headquartered in Toronto, Canada.

VIPR News:

March 23 - VIPR Industries Announces Results of Its Pitting, Trenching and Ground Magnetic Survey Exploration Program on Its Msangachuki-Londoni Gold Tenements

VIPR Industries Inc. (OTC: VIPR) ("VIPR") announces results of its recently completed reconnaissance exploration programme performed on its Twenty Gold Concessions on its Msangachuki-Londoni, Singida Gold prospect property, located in Singida, Tanzania.

JICL Consultants, a well known and respected firm providing mining and exploration services in Tanzania was sub-contracted to undertake this work which commenced in December of 2009, and recently completed in late February. Exploration work during this phase involved; Gridding, detailed geological mapping, soil sampling, Pitting, Trenching, Ground Magnetic Survey and assaying. The soil sampling, pitting and trenching programme that were completed were performed on the property to test for the presence of geochemical anomalies. Geochemical sampling was conducted in conjunction with regorith mapping and all samples were taken to Humac laboratory for analysis. Geochemical pattern is presented in figure 2 of the JICL report which can be viewed on the report posted on our website. Ten pits and three trenches were excavated in selective areas within the licenses.

"Humac Laboratories Tanzania Ltd. is a Commercial Laboratory, subsidiary of the world's famous Stewart Group Global. They do gold geochemical & assay testing, mineralogical, metallurgical and environmental analysis. Their analytical procedures are accepted internationally and recognized as being one of the foremost umpire laboratories in the world."

The objectives of the pitting and trenching were:

* To provide additional sampling and geological data on anomalies defined by ground geophysics.

* To study the overburden thickness.

* Assist in the interpretation of the structure(s) and to expose any concealed geology (if any) underneath the overburden.

* Give understanding of gold mineralization for the underneath excavated material.

Pitting and trenching work exposed a thick, pervasive overburden generally comprising fine grained red brown to orange brown silt sand at the top, followed by gravelly silt and ferricrete intercalated with silcrete. A total of thirty two soil samples and eighteen samples from pits and trenches were collected and dispatched for assaying at Humac laboratory in Mwanza, results of which are presented in figure 2 in its report which can be found and viewed on the company's website.

All 50 consolidated samples (soils, pits and trenches) were crushed, with a rifle split of 500g and pulverized to -150 mesh. The analytical method used for gold was 50g fire assay with a 0.01 ppm detection limit. Thirty samples out of fifty samples returned consistently background results below the detection limit of 0.01ppm gold. Other samples returned gold values including 0.01 g/t, 0.02g/t, 0.05g/t, 153.75g/t, 195.00g/t and 223.75 g/t Au. The reason for the background values could be possibly due to the thick nature of the overburden, which masks the gold dispersion from the bedrock. Another reason could be the high gold detection limit which was limited to 0.01 g/t Au. A repeat of analyses at a different laboratory is recommended for all samples (retained pulps) using a minimum detection limit of 0.001 g/t (1ppb) Au. The three very anomalous Au values were initially thought to be spurious, but pulp checks were re-assayed and returned consistently similar high grade Au values.

In the report presented to VIPR, JICL summarized its programme, recommending moving forward with a drilling programme over the anomalous zones defined by geochemistry to test for mineralization extension to depth. Both the anomalous soils and pit samples are located within the interpreted mafic rock units and also are proximal to the lineaments (faults/shears) from the recent ground magnetic survey. It seems the overburden has affected gold dispersion in the soils compared to the results in the pits and trenches where several values are anomalous. Hence there is a need for taking the samples at a deeper level, which can only be obtained by a RAB/DD/RC drilling programme.

In addition to the Pitting and Trenching programme, the Company has been looking at various other property acquisitions within the local vicinity to compliment its existing Tanzanian Gold Tenements, which it hopes to close on in the near term.

Javan Enock, Managing Director and Chairman of JICL Consultant commented "The reconnaissance phase has positively paved the way to prioritization of the prospect's anomalous zones and marked drill targets. We are confident that a drilling programme will critically define mineralized zones to depth consequently identifies inferred resources. The mineralization nature which seems to highly concentrate in quartz veins, silicified, chloritized and sheared greenstone rocks will be investigated down-hole to depths of 100m".

JC Barbeck, President and CEO of VIPR Industries commented, "We are pleased at the positive results exhibited by JICL's recently completed programme which is a continuation from previous exploration programmes and results received. The report indicates that a RAB/DD/RC drilling programme is recommended which the company would be eager to commence. However, prior to finalizing any decisions on the next phase of exploration, the company made the decision to consult and take the recommendations of various other third party North American firms to review the JICL data." Mr. Barbeck further commented, "The area has been proven to be positive for various other international mining companies, currently operating in this region, which includes companies such as Shanta Gold and Kilimanjaro mining, all within the immediate vicinity."